<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cayman Journal - Innate Pharma SA (IPHYF)</title>
    <description>Latest news, press releases, and SEC filings for Innate Pharma SA (IPHYF)</description>
    <link>https://caymanjournal.com/stock/IPHYF</link>
    <language>en-us</language>
    
    <copyright>Copyright 2026, Cayman Journal</copyright>
    <managingEditor>editorial@caymanjournal.com (Editorial Team)</managingEditor>
    <webMaster>webmaster@caymanjournal.com (Web Master)</webMaster>
    <lastBuildDate>Wed, 29 Jul 2026 13:48:27 GMT</lastBuildDate>
    <ttl>60</ttl>
    <atom:link href="https://caymanjournal.com/stock/IPHYF/feed.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>https://caymanjournal.com/logo.png</url>
      <title>Cayman Journal</title>
      <link>https://caymanjournal.com</link>
      <width>144</width>
      <height>144</height>
    </image>

    <item>
      <title>6-K — Innate Pharma SA</title>
      <description># 📄 What This Document Is
This is a **6-K filing**, which is a report foreign companies like Innate Pharma (based in France) must file with the U.S. SEC to share material news with American investors. Think of it as a formal press release distributed to the financial world. Today&apos;s announcement is </description>
      <link>https://caymanjournal.com/stock/IPHYF/sec-filing/0001628280-26-026676</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/IPHYF/sec-filing/0001628280-26-026676</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item><item>
      <title>6-K — Innate Pharma SA</title>
      <description># 🧾 What This Document Is

This is a **6-K form**, which is a report U.S. listed foreign companies like Innate Pharma use to announce major news to investors. Think of it as an official press release filed with the SEC.

The news here is simple: Innate Pharma&apos;s executives will be attending an inves</description>
      <link>https://caymanjournal.com/stock/IPHYF/sec-filing/0001628280-26-023471</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/IPHYF/sec-filing/0001628280-26-023471</guid>
      <pubDate>Fri, 03 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item><item>
      <title>6-K — Innate Pharma SA</title>
      <description># 🧾 What This Document Is
This is a **Form 6-K**, which is a report foreign companies like Innate Pharma file with the U.S. SEC to share important news. This specific filing is an announcement that Innate has just submitted its major yearly reports to regulators in both France and the United States</description>
      <link>https://caymanjournal.com/stock/IPHYF/sec-filing/0001628280-26-022913</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/IPHYF/sec-filing/0001628280-26-022913</guid>
      <pubDate>Thu, 02 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item>
  </channel>
</rss>